{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T21:40:14Z","timestamp":1653946814282},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00467-015-3286-0","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T10:43:22Z","timestamp":1451299402000},"page":"519-522","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should we stop dosing steroids per body surface area for nephrotics?"],"prefix":"10.1007","volume":"31","author":[{"given":"Guido","family":"Filler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"3286_CR1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0031-3955(16)32565-2","volume":"18","author":"GC Arneil","year":"1971","unstructured":"Arneil GC (1971) The nephrotic syndrome. Pediatr Clin N Am 18:547\u2013559","journal-title":"Pediatr Clin N Am"},{"key":"3286_CR2","doi-asserted-by":"crossref","unstructured":"(1984) Minimal change nephrotic syndrome in children: deaths during the first 5 to 15\u00a0years\u2019 observation. Report of the International Study of Kidney Disease in Children. Pediatrics 73:497\u2013501. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6709428","DOI":"10.1542\/peds.73.4.497"},{"key":"3286_CR3","doi-asserted-by":"crossref","first-page":"vi75","DOI":"10.1093\/ndt\/gfg1059","volume":"18","author":"G Filler","year":"2003","unstructured":"Filler G (2003) Treatment of nephrotic syndrome in children and controlled trials. Nephrol Dial Transplant 18:vi75\u2013vi78","journal-title":"Nephrol Dial Transplant"},{"key":"3286_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1681\/ASN.2012111093","volume":"24","author":"EM Hodson","year":"2013","unstructured":"Hodson EM, Craig JC (2013) Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration? J Am Soc Nephrol 24:7\u20139","journal-title":"J Am Soc Nephrol"},{"key":"3286_CR5","doi-asserted-by":"crossref","unstructured":"(1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7205481","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"3286_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie. Eur J Pediatr 152:357\u2013361","journal-title":"Eur J Pediatr"},{"key":"3286_CR7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1651-2227.1995.tb13787.x","volume":"84","author":"J Ksiazek","year":"1995","unstructured":"Ksiazek J, Wyszynska T (1995) Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 84:889\u2013893","journal-title":"Acta Paediatr"},{"key":"3286_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"3286_CR9","volume":"3","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 3, CD001533","journal-title":"Cochrane Database Syst Rev"},{"key":"3286_CR10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1046\/j.1523-1755.2000.00279.x","volume":"58","author":"M Hiraoka","year":"2000","unstructured":"Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M (2000) Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children. Kidney Int 58:1247\u20131252","journal-title":"Kidney Int"},{"key":"3286_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62\u201366","journal-title":"J Pediatr"},{"key":"3286_CR12","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317:1098","journal-title":"N Engl J Med"},{"key":"3286_CR13","doi-asserted-by":"crossref","unstructured":"Raman V, Krishnamurthy S, Harichandrakumar KT (2016) Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomised clinical trial. Pediatr Nephrol. doi: 10.1007\/s00467-015-3285-1","DOI":"10.1007\/s00467-015-3285-1"},{"key":"3286_CR14","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332","journal-title":"BMJ"},{"key":"3286_CR15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00467-010-1595-x","volume":"25","author":"RJ Brooks","year":"2010","unstructured":"Brooks RJ, Higgins GY, Webster AC (2010) Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatr Nephrol 25:2383\u20132392","journal-title":"Pediatr Nephrol"},{"key":"3286_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-198004000-00011","volume":"2","author":"WJ Jusko","year":"1980","unstructured":"Jusko WJ, Rose JQ (1980) Monitoring prednisone and prednisolone. Ther Drug Monit 2:169\u2013176","journal-title":"Ther Drug Monit"},{"key":"3286_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jps.2600650711","volume":"65","author":"WA Colburn","year":"1976","unstructured":"Colburn WA, Sibley CR, Buller RH (1976) Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs. J Pharm Sci 65:997\u20131001","journal-title":"J Pharm Sci"},{"key":"3286_CR18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2125.1978.tb01664.x","volume":"5","author":"M Davis","year":"1978","unstructured":"Davis M, Williams R, Chakraborty J, English J, Marks V, Ideo G, Tempini S (1978) Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability. Br J Clin Pharmacol 5:501\u2013505","journal-title":"Br J Clin Pharmacol"},{"key":"3286_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1399-3046.2008.00956.x","volume":"13","author":"G Filler","year":"2009","unstructured":"Filler G, Bendrick-Peart J, Strom T, Zhang YL, Johnson G, Christians U (2009) Characterization of sirolimus metabolites in pediatric solid organ transplant recipients. Pediatr Transplant 13:44\u201353","journal-title":"Pediatr Transplant"},{"key":"3286_CR20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.transproceed.2004.05.043","volume":"36","author":"G Filler","year":"2004","unstructured":"Filler G, Foster J, Berard R, Mai I, Lepage N (2004) Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Transplant Proc 36:1327\u20131331","journal-title":"Transplant Proc"},{"key":"3286_CR21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157\u20131167","journal-title":"N Engl J Med"},{"key":"3286_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/clpt.1990.167","volume":"48","author":"MR Hill","year":"1990","unstructured":"Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM (1990) Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther 48:390\u2013398","journal-title":"Clin Pharmacol Ther"},{"key":"3286_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-4347(92)80382-Z","volume":"579","author":"H Shibasaki","year":"1992","unstructured":"Shibasaki H, Furuta T, Kasuya Y (1992) Stable isotope dilution mass spectrometry for the simultaneous determination of cortisol, cortisone, prednisolone and prednisone in plasma. J Chromatogr 579:193\u2013202","journal-title":"J Chromatogr"},{"key":"3286_CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.2042-7158.1987.tb03134.x","volume":"39","author":"PF Miller","year":"1987","unstructured":"Miller PF, Wheeldon J, Brocklebank JT (1987) The separation of unbound prednisolone in plasma by centrifugal ultrafiltration. J Pharm Pharmacol 39:939\u2013941","journal-title":"J Pharm Pharmacol"},{"key":"3286_CR25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1984.tb02367.x","volume":"17","author":"G Gatti","year":"1984","unstructured":"Gatti G, Perucca E, Frigo GM, Notarangelo LD, Barberis L, Martini A (1984) Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission. Br J Clin Pharmacol 17:423\u2013431","journal-title":"Br J Clin Pharmacol"},{"key":"3286_CR26","first-page":"159","volume":"3","author":"ML Rocci Jr","year":"1982","unstructured":"Rocci ML Jr, Assael BM, Appiani AC, Edefonti A, Jusko WJ (1982) Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. Int J Pediatr Nephrol 3:159\u2013166","journal-title":"Int J Pediatr Nephrol"},{"key":"3286_CR27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF00869822","volume":"4","author":"M Rostin","year":"1990","unstructured":"Rostin M, Barthe P, Houin G, Alvinerie M, Bouissou F (1990) Pharmacokinetics of prednisolone in children with the nephrotic syndrome. Pediatr Nephrol 4:470\u2013473","journal-title":"Pediatr Nephrol"},{"key":"3286_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/adc.65.2.196","volume":"65","author":"PF Miller","year":"1990","unstructured":"Miller PF, Bowmer CJ, Wheeldon J, Brocklebank JT (1990) Pharmacokinetics of prednisolone in children with nephrosis. Arch Dis Child 65:196\u2013200","journal-title":"Arch Dis Child"},{"key":"3286_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(78)80529-0","volume":"93","author":"OC Green","year":"1978","unstructured":"Green OC, Winter RJ, Kawahara FS, Phillips LS, Lewy PR, Hart RL, Pachman LM (1978) Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr 93:299\u2013303","journal-title":"J Pediatr"},{"key":"3286_CR30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.clinthera.2011.09.015","volume":"33","author":"AC Sagcal-Gironella","year":"2011","unstructured":"Sagcal-Gironella AC, Sherwin CM, Tirona RG, Rieder MJ, Brunner HI, Vinks AA (2011) Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study. Clin Ther 33:1524\u20131536","journal-title":"Clin Ther"},{"key":"3286_CR31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1517\/17425255.1.4.641","volume":"1","author":"U Christians","year":"2005","unstructured":"Christians U, Schmitz V, Haschke M (2005) Functional interactions between P-glycoprotein and CYP3A in drug metabolism. Exper Opin Drug Metab Toxicol 1:641\u2013654","journal-title":"Exper Opin Drug Metab Toxicol"},{"key":"3286_CR32","first-page":"632","volume":"17","author":"S Baron","year":"1988","unstructured":"Baron S, Raux Demay MC, Vasmant D, Bensman A (1988) Pharmacokinetics of prednisolone in children. Study of a correlation with tolerability and therapeutic effect in nephrosis. Presse Med 17:632\u2013635","journal-title":"Presse Med"},{"key":"3286_CR33","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/ndt\/gfm092","volume":"22","author":"JH Ehrich","year":"2007","unstructured":"Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J (2007) Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 22:2183\u20132193","journal-title":"Nephrol Dial Transplant"},{"key":"3286_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2054-3581-1-17","volume":"1","author":"S Samuel","year":"2014","unstructured":"Samuel S, Scott S, Morgan C, Dart A, Mammen C, Parekh R, Nettel-Aguirre A, Eddy A, Flynn R, Pinsk M, Wade A, Arora S, Benoit G, Bitzan M, Erickson R, Feber J, Filler G, Geier P, Girardin C, Grisaru S, Tee J, Kemp K, Zappitelli M (2014) The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods. Can J Kidney Health Dis 1:17","journal-title":"Can J Kidney Health Dis"},{"key":"3286_CR35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2013.12.002","volume":"63","author":"S Samuel","year":"2014","unstructured":"Samuel S, Bitzan M, Zappitelli M, Dart A, Mammen C, Pinsk M, Cybulsky AV, Walsh M, Knoll G, Hladunewich M, Bargman J, Reich H, Humar A, Muirhead N (2014) Canadian society of nephrology commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children. Am J Kidney Dis 63:354\u2013362","journal-title":"Am J Kidney Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3286-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3286-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T21:04:34Z","timestamp":1653944674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3286"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3286-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}